Multinational pharmaceutical companies (MNCs) are facing significant challenges in China's vaccine market, as regulatory ...

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal ...

British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...

In the high-stakes world of drug development, a pill is never just a pill. Every oral drug that reaches the market has passed through a tightly managed series of steps—none more critical, or more ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

The UK government today launched its 10 Year Health Plan for the National Health Service (NHS), promising a "new era." A new ...

US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...

UK-based contract research, development and manufacturing organization Ingenza has named Nick Challoner as its new chief ...

Swiss pharma giant Novartis has announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx (secukinumab ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Fruzaqla ...

The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...